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ABSTRACT
Background: Here we aimed to evaluate: (1) Rhes
mRNA expression in mouse midbrain, (2) the effect of
Rhes deletion on the number of dopamine neurons, (3)
nigrostriatal-sensitive behavior during aging in knock-
out mice.
Methods: Radioactive in situ hybridization was
assessed in adult mice. The beam-walking test was
executed in 3-, 6- and 12-month-old mice. Immunohis-
tochemistry of midbrain tyrosine hydroxylase (TH)–pos-
itive neurons was performed in 6- and 12-month-old
mice.
Results: Rhes mRNA is expressed in TH-positive neu-
rons of SNpc and the ventral tegmental area. More-
over, lack of Rhes leads to roughly a 20% loss of
nigral TH-positive neurons in both 6- and 12-month-
old mutants, when compared with their age-matched
controls. Finally, lack of Rhes triggers subtle alterations
in motor performance and coordination during aging.
Conclusions: Our findings indicate a fine-tuning role of
Rhes in regulating the number of TH-positive neurons
of the substantia nigra and nigrostriatal-sensitive motor
behavior during aging. VC 2016 International Parkinson
and Movement Disorder Society
Key Words: Rhes; Rasd2; dopamine neurons; mid-
brain; TH-positive neurons
Rhes is a small GTP-binding protein highly enriched
in the striatum,1 developmentally regulated by thyroid
hormone2,3 and by dopamine (DA) innervation in
adult rat brain.4 Within the striatum, Rhes mRNA is
localized in GABAergic medium-sized projection neu-
rons of mice and humans,5-7 as well as in large aspiny
cholinergic interneurons,8 where it modulates DA-
dependent transmission. Recent findings showed that
Rhes binds to and activates mTORC1, a key modula-
tor of several biological processes,9 including levodopa
(L-dopa)–induced dyskinesia.10 Accordingly, lack of
Rhes attenuates L-dopa-induced motor disturbances in
hemiparkinsonian mutants. In addition, Snyder and
coworkers demonstrated that Rhes influences Hunting-
ton’s disease physiopathology through its ability to act
as a selective E3 ligase of mutant huntingtin.11 Fur-
thermore, they also reported the ability of this striatal
GTPase to bind to Beclin-1 and, in turn, activate
autophagy-related processes.12
In addition to its enriched striatal localization, Rhes
mRNA is also expressed in the hippocampus, olfac-
tory tubercle, anterior nuclei of the thalamus, inferior
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colliculus, and granular layer of cerebellum.1 Here, we
evaluated the Rhes mRNA expression pattern in mid-
brain regions and investigated its potential involve-
ment in regulating the number and density of DA
neurons, as well as nigrostriatal-sensitive behavior
during aging.
Materials and Methods
Animals
Male Rhes1/1 and Rhes2/2 mice without PGK-neo
cassette,8 backcrossed to F11 generation to the
C57BL/6J strain, were used in the present study.
Experiments were performed in conformity with pro-
tocols approved by the veterinary department of the
Italian Ministry of Health and in accordance with the
ethical and safety rules and guidelines for the use of
animals in biomedical research provided by the rele-
vant Italian laws and European Union’s directives (no.
86/609/EC). All efforts were made to minimize the
animals’ suffering.
Neuroanatomical Studies
Single and double in situ hybridization (ISH) analy-
ses were performed according to protocols previously
described.7,13 Digoxigenin-(Rhes, TH, Gad67) and
fluorescein-conjugated (TH) or 35S-labeled (Rhes) anti-
sense riboprobes were used. Nitro blue tetrazolium
(NBT)/ 5-bromo-4-chloro-3-indolyl-phosphate (BCIP)
substrate in combination with 2-hydroxy-3-naphtoic
acid-20-phenylanilide phosphate (HNPP)/Fast Red Flu-
orescent Detection Set was used in double ISH. For
radioactive ISH, slides were exposed to Biomax MR
x-ray films.
For combined ISH and immunohistochemistry
(IHC), animals were perfused transcardially with 4%
paraformaldehyde (PFA) and brain sections 50lm
thick were obtained with a vibratome (Leica Microsys-
tems). Free-floating sections were incubated over night
at 4 8C with a primary mouse anti-TH antibody
(1:400, Millipore), followed by a 2-hour incubation at
room temperature with an Alexa Fluor 488 goat anti-
mouse (1:500, Molecular Probes). Following IHC, ISH
analysis was performed as described above using a
fluorescein-labeled Rhes antisense riboprobe. HNPP/
Fast Red was used as labeling method taking care to
avoid quenching the Alexa Fluor 488 fluorescence
masking the TH signal in dopaminergic neurons.
Images were taken with a SP8 confocal microscope
(Leica).
Behavioral Tests
Motor performance and coordination of mice was
evaluated with a beam-walking test.14,15 Mice were
trained to traverse the length of a Plexiglas beam.
Mice received 2 days of training before testing that
ended when all animals complete 5 unassisted runs
across the length of a Plexiglas beam (4 sections of
25 cm each, 1 m total length, with a different width: 1,
2, 3, and 4 cm). On test day, a mesh grid (1 cm2) of
corresponding width was placed over the beam. Mice
were videotaped for 5 trials. An error was counted
when, during a movement, a limb slipped through the
grid. An individual animal could make a maximum of
4 slips (errors) per step. Time to traverse, number of
steps, and errors per step scores were calculated across
5 trials and averaged for each group.15
Immunohistochemistry
After behavioral tests, mice were anesthetized and
perfused for immunohistochemistry. Three coronal
sections (40 lm thick) from striatum (A: 1.10, 0.74,
0.38 mm from bregma) and 6 sections from the SNpc/
ventral tegmental area (VTA; A: -2.92 to -.64 mm
from bregma) were cut on a vibratome, according to
Paxinos and Franklin.16 SNpc/VTA sections were
immunoreacted with an anti-TH antibody, whereas
sections from the striatum were immunoreacted with
an anti–glutamic acid decarboxylase 67 (GAD67) anti-
body. Reaction was amplified as described.17
Stereological analysis of total number and density of
TH-positive neurons in the SNpc were counted on both
hemispheres, using software (Stereologer) linked to a
motorized stage on a light microscope.18 The SNpc
region was outlined at low magnification (23), and
sampling of cells was achieved using automatically
randomized sampling and an optical dissector (503
50315 mm). Cells were sampled with a 403 objective
through a defined depth with a guard zone of 2 lm.
Coefficient of error ranged from 0.05 to 0.1.18 GAD67
and TH-positive neurons of the VTA were counted in
both hemispheres. Images were captured and evaluated
with Pixelink software. The absolute number of
GAD67 and TH-positive neurons obtained for each
VTA and striatal level showed no differences; therefore,
the data obtained were pooled together.
Statistics
Data are presented as mean6 SEM. For all parame-
ters, differences were evaluated by 1-way analysis of
variance (ANOVA) followed by the Newman-Keuls
post hoc test. Significance was set at P< 0.05.
Results
Rhes Is Coexpressed With TH-Positive
Neurons in SNpc and VTA
To characterize Rhes expression in the midbrain, we
performed in situ hybridization on coronal sections of
adult mice labeled with a specific 35S-labeled riboprobe
for Rhes (Fig. 1A-D, A0-D0). Results indicated expres-
sion of Rhes in a domain along the anteroposterior
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FIG. 1. Rhes expression in midbrain DA neurons of the SNpc and VTA. (A-D0) Radioactive ISH on coronal sections of adult mice hybridized with a
specific 35S-labeled Rhes riboprobe show expression of Rhes mRNA in midbrain territories corresponding to SNpc and VTA (A-A0, C-C0). Black-
boxed regions in A-D are shown at higher magnification in A0-D0. (B, B0, D, D0) Control RNase-treated sections showing the specificity of the Rhes
riboprobe. (E-H) Nonradioactive ISH on parallel coronal sections of adult mouse brains labeled with specific probes for TH (F), Rhes (G), and Gad67
(H). Images show the area highlighted by the red-boxed region in the schematic view (E). TH-expressing cells are localized in the SNpc territory,
where it is also evident Rhes expression (F-G). Conversely, Rhes is not expressed at detectable levels in the SNpr, where Gad67-positive cells are
present (G-H). (I-J00) Double ISH on coronal sections of adult brains labeled with specific probes for Rhes (blue precipitate in I, I0, J0) and TH (red flu-
orescence in I00, J00), analyzed in SNpc and VTA (black-boxed panels in I). Rhes expression is detectable in the SNpc and VTA regions, where it
colocalizes with TH (arrows in I-J00). (K-K000) Representative confocal image of brain coronal section processed for combined in situ hybridization and
immunohistochemical labeling. Boxed region in K is shown at higher magnification in K0-K000. Arrows highlight neurons coexpressing Rhes mRNA
and TH protein. Scale bar: 1.2 mm (A, B, C, D); 300 mm (A0, B0, C0, D0, F-I); 75 mm (I0-J00). [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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extent of the ventral midbrain, corresponding to where
SN and VTA are localized (Fig. 1A, A0, C, C0). The
specificity of the riboprobe labeling was confirmed by
treating parallel adjacent sections with RNase A before
the hybridization step (Fig. 1B-B0, D-D0). DA- and
GABA-expressing cells collectively constitute the 2
main neuronal populations of the ventral midbrain,
having partially overlapping localization domains in
both the SN and VTA, but showing very little, if any,
colocalization.19 To assess whether Rhes-expressing
neurons could belong to 1 of these 2 populations, we
compared, by means of ISH on adjacent sections, the
expression profile of Rhes with that of TH and Gad67
mRNA, which encode DA- and GABA-synthetic
enzymes, respectively. Results showed that Rhes is
expressed in the same territory as TH-expressing cells
(ie, the SNpc and VTA; Fig. 1E-G). In contrast, ISH
data did not show any obvious expression of Rhes in
the SN pars reticulata (SNpr), where Gad67-positive
cells are mainly present (Fig. 1G-H). These results led
us to hypothesize that Rhes might be expressed in mid-
brain DA neurons. Hence, we performed double ISH
combining Rhes- and TH-specific riboprobes, focusing
our analysis on SNpc and VTA (Fig. 1I-J00). To further
confirm such a hypothesis, we combined fluorescent
immunohistochemistry and HNPP/Fast Red in situ
hybridization protocol to examine the colocalization of
TH protein and Rhes mRNA (Fig. 1K, K0-K000). Results
demonstrated that Rhes mRNA expression could be
detected in a large extent of TH-positive neurons, both
in SNpc (Fig. 1I, I0-I00, K, K0-K000) and VTA (Fig. 1I, J0-
J00, K, K0-K000).
Evaluation of Midbrain TH- and Striatal
GAD67-Positive Neurons in Rhes Mutants
A mild decrease in the total number of TH-positive
nigral neurons was found in Rhes2/2 mutants, com-
pared with age-matched Rhes1/1 (6 months, F1,2356.9,
P<0.05; 12 months, F1,185 18.14, P< 0.001; Fig. 2A-
B). Also, density of TH-positive neurons in SNpc of 6-
and 12-month-old mutants demonstrated a significant
decrease (6 months, F1,235 10.07, P< 0.005; 12
months, F1,1854.42, P< 0.05; not shown). Conversely,
the number of TH-positive neurons in VTA and the
number of GAD67-positive neurons in striatum at 12-
month of age were indistinguishable between genotypes
(VTA: F1,1850.99, P5 0.33), Fig. 2D; striatum:
F1,1850.66, P5 0.43, Fig. 2C).
To explore whether lack of Rhes influences coordi-
nation and motor behavior during aging, we per-
formed the beam-walking test, a well-established
behavioral paradigm to evaluate the integrity of the
nigrostriatal system.14 Rhes2/2 and Rhes1/1 of 3, 6,
and 12 months of age were tested (Fig. 2E).
The 3-, 6- and 12- month-old mutants made a sig-
nificantly higher number of steps to traverse the beam,
compared with controls (3 months, F1,395 4.82,
P< 0.05; 6 months, F1,4254.25, P<0.05; 12 months,
F1,45513.44, P< 0.005).
Three-month old mutants spent similar time to traverse
the beam (F1,3950.58, P50.45). In contrast, 6- and 12-
month-old Rhes2/2 mice spent a significantly longer time
to traverse the beam (6 months, F1,425 4.18, P<0.05;
12 months, F1,455 4.06, P< 0.05).
Moreover, 3- and 6-month-old Rhes2/2 mice made
similar errors per step to traverse the beam (3 months,
F1,3950.37, P5 0.55; 6 months, F1,425 1.96,
P5 0.169). In contrast, 12-month-old mutants made
significantly more errors per step in traversing the
beam (F1,45513.18, P< 0.005; Fig. 2E).
Discussion
In the present study we documented that Rhes mRNA,
beyond its main striatal localization in GABAergic
medium spiny neurons,5-7 cholinergic large aspiny inter-
neurons,8 and the hippocampus,6 is also expressed,
although to a lesser extent, in TH-positive neurons of
SNpc and VTA of the mouse midbrain. In addition, we
showed that lack of Rhes leads to a mild, although sig-
nificant, 20% of nigral TH-positive neuronal loss in both
6- and 12-month-old mutant animals, when compared
with their age-matched controls. Moreover, in Rhes
knockouts we found subtle motor coordination deficits,
as measured by the beam-walking test, during aging.14,15
Although it is still unclear whether such motor defect
is selectively associated with a SNpc dysfunction or
rather is linked to striatal abnormalities,8,11 our data
point to an unexpected influence of Rhes in selectively
regulating the number of nigral DA midbrain neurons,
but not those of VTA or striatal projecting neurons.
This observation fits with previous data evidencing a
role for Rhes in modulating signaling pathways impli-
cated in neuronal survival, such as mTOR20 and
Beclin-1.12 On the other hand, based on previous in
vitro findings indicating that Rhes, by influencing Gai-
coupled GPCR signaling, affects the voltage-dependent
inhibition of Cav2.2 channels,21 we cannot exclude
involvement of Rhes in regulating local calcium homeo-
stasis and thereby neurosecretion,22 which, in turn,
could explain the progressive detrimental effect on the
nigrostriatal survival pathway seen in mutants.
Present data showing that the thyroid target gene
Rhes is expressed in both SNpc and VTA midbrain
regions significantly enlarges the conceptual meaning
of this gene, previously thought to be expressed only
in dopaminoceptive neurons.5,6
In conclusion, even though we argue that Rhes does
not have a causative role in Parkinson’s disease, how-
ever, considering its peculiar expression throughout
DA system, we suggest that this protein could regulate
such neurotransmission at both at pre- and postsynap-
tic sites.
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FIG. 2. DA neurons in the SNpc and VTA and analysis of motor performance and coordination in Rhes2/2 and Rhes1/1 mice. Representative photo-
micrographs of brain coronal sections showing TH-positive cells in the SNpc of Rhes2/2 (center) and Rhes1/1 (left) mice of 6 (A) and 12 (B) months
(scale bar5 50 mm). Histograms (A-B, right) showing stereological quantification of TH-positive neurons in the SNpc of Rhes2/2 (black column) and
Rhes1/1 (white column) mice of 6 (A, right) and 12 (B, right) months. Results are mean6SEM of total number of TH-positive neurons (6 months:
Rhes1/1 n5 15, Rhes2/2 n5 10; 12 months: Rhes1/1 n5 12, Rhes2/2 n5 8). Histogram (C) showing quantification of Gad67-positive neurons in the
striatum of Rhes2/2 (black column) and Rhes1/1 (white column) mice of 12 months. Results are mean6SEM of total number of Gad67-positive neu-
rons expressed as a percentage of Rhes1/1 (control) mice (12 months: Rhes1/1 n5 12, Rhes2/2 n58). Histogram (D) shows quantification of TH-
positive neurons in the VTA of Rhes2/2 (black column) and Rhes1/1 (white column) mice of 12 months. Results are mean6SEM of total number of
TH-positive neurons expressed as a percentage of Rhes1/1 (control) mice (12 months: Rhes1/1 n512, Rhes2/2 n58). Three separate groups of
Rhes1/1 and Rhes2/2 mice of 3, 6, and 12 months old were tested in the beam-walking test (E). Results are mean6SEM of the number of steps,
time to traverse the beam in seconds (left axis), and errors3 step (right axis) (E) (3 months: Rhes1/1 n520, Rhes2/2 n521; 6 months: Rhes1/1
n525, Rhes2/2 n519; 12 months: Rhes1/1 n5 22, Rhes2/2 n5 25). Statistical significance was determined by 1-way ANOVA followed by the
Newman–Keuls post hoc test. *P< 0.05, **P< 0.005, versus Rhes1/1 (control) mice at the same age.
Moreover, we can also hypothesize that putative
downregulation of Rhes might affect the vulnerability
of nigral cells to death triggered by aging processes
and/or environmental insults.
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